Evidence map›Paper›PMID 26682816›Full record

ArticleBiophysical journal2015

Phosphorylating Titin's Cardiac N2B Element by ERK2 or CaMKIIδ Lowers the Single Molecule and Cardiac Muscle Force.

John Perkin, Rebecca Slater, Giorgia Del Favero, Thomas Lanzicher, Carlos Hidalgo, Brian Anderson, John E Smith, Orfeo Sbaizero, Siegfried Labeit, Henk Granzier

Abstract read
In one paragraph

Article in Biophysical journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Review
  3. Novel Drug Targets in Diastolic Heart Disease.International journal of molecular sciences · 2025
    Review
  4. Review
  5. Postprandial cardiac hypertrophy is sustained by mechanics, epigenetic, and metabolic reprogramming in pythons.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Article
  7. Article
  8. Titin: roles in cardiac function and diseases.Frontiers in physiology · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Atomic Force Microscopy (AFM) Applications in Arrhythmogenic Cardiomyopathy.International journal of molecular sciences · 2022
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Titin mutations and muscle disease.Pflugers Archiv : European journal of physiology · 2019
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

John PerkinDepartment of Cellular and Molecular Medicine, University of Arizona, Tucson, Arizona.
Rebecca SlaterDepartment of Cellular and Molecular Medicine, University of Arizona, Tucson, Arizona.
Giorgia Del FaveroDepartment of Cellular and Molecular Medicine, University of Arizona, Tucson, Arizona; Engineering and Architecture Department, University of Trieste, Trieste, Italy.
Thomas LanzicherDepartment of Cellular and Molecular Medicine, University of Arizona, Tucson, Arizona; Engineering and Architecture Department, University of Trieste, Trieste, Italy.
Carlos HidalgoDepartment of Cellular and Molecular Medicine, University of Arizona, Tucson, Arizona.
Brian AndersonDepartment of Cellular and Molecular Medicine, University of Arizona, Tucson, Arizona.
John E SmithDepartment of Cellular and Molecular Medicine, University of Arizona, Tucson, Arizona.
Orfeo SbaizeroEngineering and Architecture Department, University of Trieste, Trieste, Italy.
Siegfried LabeitDepartment of Integrative Pathophysiology, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.
Henk GranzierDepartment of Cellular and Molecular Medicine, University of Arizona, Tucson, Arizona. Electronic address: granzier@email.arizona.edu.

Funding

X-RAY STUDIES OF NEUROFIBRILLARY TANGLES IN ALZHEIMER'S DISEASE BRAIN TISSUEP41RR008630 · NCRR · ILLINOIS INSTITUTE OF TECHNOLOGY · PI IRVING, THOMAS C · 2001 to 2011
$14.4M
Function of Giant Sarcomere Matrix Proteins in MuscleR01HL062881 · NHLBI · WASHINGTON STATE UNIVERSITY · PI GRANZIER, HENK L. · 1999 to 2018
$6.4M
Titin-Based Adaptations of Cardiac FunctionR01HL115988 · NHLBI · UNIVERSITY OF ARIZONA · PI GRANZIER, HENK L. · 2013 to 2019
$2.3M
Role of the Giant Protein Titin in Skeletal Muscle Structure and FunctionR01AR060697 · NIAMS · UNIVERSITY OF ARIZONA · PI GRANZIER, HENK L. · 2011 to 2015
$1.7M
NCRR NIH HHS P41 RR008630NHLBI NIH HHS HL062881NHLBI NIH HHS HL115988NHLBI NIH HHS R01 HL062881NHLBI NIH HHS R01 HL115988NIAMS NIH HHS R01 AR060697
6 · The paper itself

Abstract

Titin is a large filamentous protein that is responsible for the passive force of the cardiac sarcomere. Titin's force is generated by its I-band region, which includes the cardiac-specific N2B element. The N2B element consists of three immunoglobulin domains, two small unique sequence insertions, and a large 575-residue unique sequence, the N2B-Us. Posttranslational modifications of the N2B element are thought to regulate passive force, but the underlying mechanisms are unknown. Increased passive-force levels characterize diastolic stiffening in heart-failure patients, and it is critical to understand the underlying molecular mechanisms and identify therapeutic targets. Here, we used single-molecule force spectroscopy to study the mechanical effects of the kinases calcium/calmodulin-dependent protein kinase II delta (CaMKIIδ) and extracellular signal-regulated kinase 2 (ERK2) on the single-molecule mechanics of the N2B element. Both CaMKIIδ and ERK2 were found to phosphorylate the N2B element, and single-molecule force spectroscopy revealed an increase in the persistence length (Lp) of the molecule, indicating that the bending rigidity of the molecule was increased. Experiments performed under oxidizing conditions and with a recombinant N2B element that had a simplified domain composition provided evidence that the Lp increase requires the N2B-Us of the N2B element. Mechanical experiments were also performed on skinned myocardium before and after phosphorylation. The results revealed a large (∼30%) passive force reduction caused by CaMKIIδ and a much smaller (∼6%) reduction caused by ERK2. These findings support the notion that the important kinases ERK2 and CaMKIIδ can alter the passive force of myocytes in the heart (although CaMKIIδ appears to be more potent) during physiological and pathophysiological states.

Indexed as

Mechanical PhenomenaAmino Acid SequenceAnimalsBiomechanical PhenomenaCalcium-Calmodulin-Dependent Protein Kinase Type 2ConnectinFemaleHumansMiceMitogen-Activated Protein Kinase 1Molecular Sequence DataMyocardiumPhosphorylationStress, MechanicalCalcium-Calmodulin-Dependent Protein Kinase Type 2ConnectinMitogen-Activated Protein Kinase 1

Identifiers

PMID26682816
PMCPMC4701010

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.